Wednesday, February 10, 2010, 7:33pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Nanosphere, Inc. (NSPH)

At 5:00AM SGT: 4.57 USD   0.00 (0.00%)  
 MORE ON NSPH 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Nanosphere, Inc. (NGM:NSPH) Delayed quote dataEdit
Last Trade:4.57 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:4.57
Open:N/A
Bid:N/A
Ask:7.45 x 1100
1y Target Est:7.75
Day's Range:N/A - N/A
52wk Range:2.71 - 8.61
Volume:0
Avg Vol (3m):61,279.4
Market Cap:126.36M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add NSPH to Portfolio   Download Data

 HEADLINES 
•Nanosphere to Report Fourth Quarter and Year-End 2009 Results and Hold Investor Call Wednesday, February 24, 2010
GlobeNewswire (Mon, Feb 8)
•Nanosphere Announces FDA Clearance to Update the Package Insert for Its Respiratory Virus Assay to Include Reactivity With Influenza A in Cultured Clinical Isolates Containing 2009 H1N1 Influenza Virus
GlobeNewswire (Tue, Nov 24)
•Nanosphere Announces FDA Submission of 510(k) Documentation for Its Verigene Cardiac Troponin I Assay
GlobeNewswire (Wed, Nov 18)
•NANOSPHERE INC Financials
EDGAR Online Financials (Wed, Nov 11)
•NANOSPHERE INC Earnings Call scheduled for 5:00 pm ET today
CCBN (Fri, Nov 6)
•NANOSPHERE INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Of
EDGAR Online (Fri, Nov 6)
•Nanosphere Announces Third Quarter 2009 Results
GlobeNewswire (Fri, Nov 6)
•NANOSPHERE INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
•Nanosphere, Inc. to Present at the 2009 Credit Suisse Healthcare Conference
GlobeNewswire (Mon, Oct 26)
•NANOSPHERE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 21)
More Headlines for NSPH...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.44
EPS Est (in 2 years) (Dec-10) :-1.20
Avg Rec (current)*:1.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices